Double Blind Placebo Controlled Dose Ranging Study for the Assessment of Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Multiple Ascending Oral Doses of GLPG0778 in Healthy Male Subjects.
Phase of Trial: Phase I
Latest Information Update: 19 Dec 2011
At a glance
- Drugs Solcitinib (Primary)
- Indications Osteoarthritis
- Focus Adverse reactions; Biomarker
- 01 Aug 2011 Status changed from recruiting to completed, according to ClinicalTrial.gov record.
- 15 Apr 2011 Status changed from not yet recruiting to recruiting, according to ClinicalTrials.gov.
- 12 Jan 2011 New trial record